Current Value
$8.571 Year Return
Current Value
$8.571 Year Return
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XBI | 50.23% | $4.82B | 0.35% |
| GNOM | 50.13% | $44.57M | 0.5% |
| IWC | 47.55% | $818.14M | 0.6% |
| IBB | 46.60% | $5.26B | 0.45% |
| PBE | 45.67% | $223.19M | 0.58% |
| ARKG | 45.01% | $1.02B | 0.75% |
| IWM | 44.21% | $63.72B | 0.19% |
| VTWO | 44.05% | $12.52B | 0.07% |
| GSSC | 44.01% | $561.54M | 0.2% |
| IWN | 43.94% | $10.96B | 0.24% |
| FBT | 43.21% | $1.01B | 0.54% |
| IWO | 42.79% | $11.60B | 0.24% |
| PSC | 42.64% | $752.65M | 0.38% |
| BBH | 42.49% | $330.62M | 0.35% |
| PRFZ | 42.46% | $2.36B | 0.34% |
| PINK | 42.23% | $130.57M | 0.5% |
| FYX | 42.20% | $817.02M | 0.6% |
| SCHA | 41.98% | $17.26B | 0.04% |
| VIOO | 41.91% | $2.85B | 0.1% |
| XSVM | 41.76% | $566.08M | 0.37% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| LFVN | 0.04% | $168.68M | +123.71% | 1.22% |
| CL | 0.19% | $74.88B | -3.64% | 2.19% |
| DFDV | 0.27% | $300.56M | +2,130.16% | 0.00% |
| EQX | -0.32% | $4.42B | +6.96% | 0.00% |
| BCE | -0.37% | $21.07B | -27.36% | 10.97% |
| IMDX | 0.38% | $86.94M | -0.65% | 0.00% |
| ADC | -0.39% | $7.93B | +16.41% | 4.21% |
| FARO | 0.47% | $848.40M | +170.44% | 0.00% |
| SBRA | -0.53% | $4.39B | +20.18% | 6.50% |
| SAVA | 0.60% | $97.10M | -81.34% | 0.00% |
| API | 0.60% | $275.52M | +57.45% | 0.00% |
| ED | 0.66% | $36.00B | +12.64% | 3.34% |
| AMT | 0.67% | $104.32B | +14.40% | 3.00% |
| LTM | 0.71% | $12.63B | -95.46% | 2.42% |
| KR | 0.77% | $46.43B | +38.38% | 1.85% |
| CCEC | -0.80% | $1.02B | +3.91% | 2.58% |
| GHI | 0.81% | $272.81M | -20.46% | 12.24% |
| E | 0.86% | $49.09B | +6.89% | 6.60% |
| CCRN | 0.87% | $429.13M | -3.89% | 0.00% |
| MDLZ | 0.90% | $90.07B | +4.85% | 2.72% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| ILTB | 0.03% | $595.04M | 0.06% |
| CMBS | -0.08% | $449.66M | 0.25% |
| STOT | 0.10% | $254.07M | 0.45% |
| UGA | 0.18% | $72.33M | 0.97% |
| SPIP | 0.18% | $969.51M | 0.12% |
| TLTW | -0.19% | $1.15B | 0.35% |
| BGRN | -0.21% | $404.12M | 0.2% |
| IAGG | -0.32% | $10.44B | 0.07% |
| DBC | 0.32% | $1.23B | 0.87% |
| IGOV | -0.38% | $1.22B | 0.35% |
| BSCP | -0.40% | $3.28B | 0.1% |
| GSY | 0.40% | $2.74B | 0.22% |
| SHYM | 0.46% | $357.13M | 0.35% |
| BSCW | 0.48% | $910.58M | 0.1% |
| IBDU | 0.48% | $2.69B | 0.1% |
| GTO | -0.54% | $1.97B | 0.35% |
| USO | -0.54% | $1.13B | 0.6% |
| IBDV | 0.55% | $1.91B | 0.1% |
| SLQD | -0.55% | $2.29B | 0.06% |
| DBO | -0.55% | $228.24M | 0.77% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| DNLI | 47.81% | $2.16B | -30.05% | 0.00% |
| BEAM | 44.88% | $2.00B | -15.33% | 0.00% |
| CLDX | 44.13% | $1.47B | -38.43% | 0.00% |
| IDYA | 43.50% | $1.92B | -34.15% | 0.00% |
| ATXS | 42.63% | $323.37M | -36.33% | 0.00% |
| FRST | 42.33% | $272.94M | +3.37% | 3.60% |
| EYPT | 41.66% | $664.72M | +12.07% | 0.00% |
| ARWR | 41.50% | $2.33B | -32.59% | 0.00% |
| TCBK | 41.25% | $1.39B | +10.35% | 3.08% |
| KFY | 41.06% | $3.88B | +10.79% | 2.14% |
| HWC | 40.77% | $5.18B | +29.68% | 2.79% |
| EWBC | 40.63% | $14.81B | +47.90% | 2.13% |
| FIBK | 40.60% | $3.21B | +10.39% | 6.08% |
| STEL | 40.43% | $1.51B | +31.48% | 1.86% |
| XPER | 40.36% | $370.07M | +2.27% | 0.00% |
| LKFN | 39.92% | $1.65B | +6.52% | 3.04% |
| KEY | 39.79% | $19.95B | +27.54% | 4.47% |
| MCB | 39.76% | $783.09M | +73.87% | 0.00% |
| FFBC | 39.70% | $2.45B | +17.36% | 3.73% |
| EBC | 39.62% | $3.37B | +14.04% | 2.98% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VIXY | -30.47% | $164.54M | 0.85% |
| BTAL | -29.88% | $296.22M | 1.43% |
| TAIL | -28.70% | $99.63M | 0.59% |
| IBTF | -16.54% | $1.99B | 0.07% |
| XONE | -15.46% | $625.28M | 0.03% |
| WEAT | -14.82% | $117.15M | 0.28% |
| JMST | -14.67% | $4.06B | 0.18% |
| IBTG | -13.85% | $1.92B | 0.07% |
| BILS | -13.44% | $3.81B | 0.1356% |
| SPTS | -13.00% | $5.80B | 0.03% |
| IVOL | -12.80% | $347.03M | 1.02% |
| IBTH | -12.70% | $1.62B | 0.07% |
| SCHO | -12.64% | $11.03B | 0.03% |
| TPMN | -12.59% | $30.70M | 0.65% |
| IBD | -12.00% | $385.27M | 0.43% |
| CGSM | -11.86% | $709.45M | 0.25% |
| GBIL | -11.69% | $6.37B | 0.12% |
| UTWO | -11.53% | $379.52M | 0.15% |
| VGSH | -10.98% | $22.80B | 0.03% |
| IBTI | -10.74% | $1.06B | 0.07% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| LITB | -10.04% | $21.24M | -78.57% | 0.00% |
| K | -8.32% | $27.76B | +41.17% | 2.85% |
| MKTX | -7.74% | $8.22B | +9.03% | 1.38% |
| CME | -7.65% | $99.39B | +40.68% | 3.86% |
| MCK | -6.71% | $88.11B | +20.93% | 0.40% |
| NOC | -6.09% | $71.81B | +14.14% | 1.69% |
| HUSA | -5.91% | $19.66M | -19.53% | 0.00% |
| OHI | -5.60% | $10.56B | +7.99% | 7.35% |
| SYPR | -5.14% | $48.49M | +14.05% | 0.00% |
| CYCN | -5.07% | $10.59M | +46.35% | 0.00% |
| GFI | -4.98% | $21.56B | +57.55% | 2.31% |
| NEUE | -4.57% | $61.24M | +29.92% | 0.00% |
| PACS | -4.36% | $2.02B | -56.52% | 0.00% |
| CTRE | -3.77% | $5.88B | +20.77% | 4.04% |
| CI | -3.48% | $85.59B | -1.55% | 1.81% |
| CBOE | -3.14% | $24.23B | +35.36% | 1.09% |
| VSA | -2.88% | $8.67M | -19.04% | 0.00% |
| LMT | -2.73% | $108.37B | -0.75% | 2.81% |
| PPC | -2.56% | $10.84B | +33.46% | 0.00% |
| CNC | -2.47% | $16.81B | -49.40% | 0.00% |
Yahoo
RESEARCH TRIANGLE PARK, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated April 25, 2025 were elected as directors of the Company at the Annual General and Special Meeting of Shareholders held in New York, New York on June 3, 2025. Detailed results of the vote for the election of directors are set out below: Name of NomineeVotes For% Votes ForVotes Withheld% V
Yahoo
Fennec Pharmaceuticals ( NASDAQ:FENC ) First Quarter 2025 Results Key Financial Results Revenue: US$8.75m (down 66...
Yahoo
Fennec Pharmaceuticals Inc (FENC) reports an 18% increase in net product sales, while navigating cash burn and operational expenses.
Yahoo
Q1 2025 Fennec Pharmaceuticals Inc Earnings Call
SeekingAlpha
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ETCompany ParticipantsRobert Andrade - Chief Financial...
Yahoo
Fennec Pharmaceuticals (FRX.TO) rose nearly 10% in U.S. pre-market trading on Tuesday after saying i
